Merck Wins 1st State Fosamax Trial In NJ

Law360, New York (February 14, 2011, 4:19 PM EST) -- A New Jersey jury sided with Merck & Co. Inc. on Monday in the first Fosamax case to go to trial in a state court, freeing the company from claims its osteoporosis drug was to blame for a woman's jaw bone decay.

The jury in the Superior Court for Atlantic County, New Jersey, found in favor of Merck, rejecting claims by the plaintiff — who took Fosamax from 1999 to 2006 — that she suffered jaw problems linked to her use of the drug after having...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.